Should a Psychedelic Therapist Be Able to Continue Therapy for Their Patients Beyond Formal Integration Sessions?
Following psychedelic integration therapy, should the same lead therapist continue psychotherapy with their patients?

Following psychedelic integration therapy, should the same lead therapist continue psychotherapy with their patients?

Here, we examine hype in the context of a perennial tension at the heart of patenting communication: between advertising innovation and keeping it secret.

In short, 109’s creators’ stated intent to make psilocybin therapy accessible to help the growing mental health care crisis has resulted in a policy that doesn’t allow for any of it.

A brief sketch of the potential for Rights of Nature legislation to safeguard sacred plant medicines by recognizing them as rights holders unto themselves.

Psychedelic science appears to ignore many of the lessons learned from decades of research in other fields.

As a historian of psychoactive pharmaceuticals in the 20th century U.S., I see history rhyming in potentially dangerous ways in the current psychedelic boom.

Without committing to open science practices, we risk producing a psychedelics industry with the same efficacy and integrity as the self-help industry.

There are a number of unique issues that psychedelics present in a clinical setting that are yet to be adequately addressed.

The essays collected in this symposium represent a diversity of viewpoints about the field of psychedelic studies and its potential futures, rather than a consensus perspective. Despite differences in opinion, disciplinary vantage point, and level of analysis, they are united in calling attention to significant topics that have been underexplored in the dominant discourse about…
